Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
α4β7 independent pathway for CD8+ T cell–mediated intestinal immunity to rotavirus
Nelly A. Kuklin, … , Eugene C. Butcher, Harry B. Greenberg
Nelly A. Kuklin, … , Eugene C. Butcher, Harry B. Greenberg
Published December 15, 2000
Citation Information: J Clin Invest. 2000;106(12):1541-1552. https://doi.org/10.1172/JCI10927.
View: Text | PDF
Article

α4β7 independent pathway for CD8+ T cell–mediated intestinal immunity to rotavirus

  • Text
  • PDF
Abstract

Rotavirus (RV), which replicates exclusively in cells of the small intestine, is the most important cause of severe diarrhea in young children worldwide. Using a mouse model, we show that expression of the intestinal homing integrin α4β7 is not essential for CD8+ T cells to migrate to the intestine or provide immunity to RV. Mice deficient in β7 expression (β7–/–) and unable to express α4β7 integrin were found to clear RV as quickly as wild-type (wt) animals. Depletion of CD8+ T cells in β7–/– animals prolonged viral shedding, and transfer of immune β7–/– CD8+ T cells into chronically infected Rag-2–deficient mice resolved RV infection as efficiently as wt CD8+ T cells. Paradoxically, α4β7hi memory CD8+ T cells purified from wt mice that had been orally immunized cleared RV more efficiently than α4β7low CD8+ T cells. We explained this apparent contradiction by demonstrating that expression of α4β7 on effector CD8+ T cells depends upon the site of initial antigen exposure: oral immunization generates RV-specific CD8+ T cells primarily of an α4β7hi phenotype, but subcutaneous immunization yields both α4β7hi and α4β7low immune CD8+ T cells with anti-RV effector capabilities. Thus, α4β7 facilitates normal intestinal immune trafficking to the gut, but it is not required for effective CD8+ T cell immunity.

Authors

Nelly A. Kuklin, Lusijah Rott, Jama Darling, James J. Campbell, Manuel Franco, Ningguo Feng, Werner Müller, Norbert Wagner, John Altman, Eugene C. Butcher, Harry B. Greenberg

×

Figure 9

Options: View larger image (or click on image) Download as PowerPoint
Tetramer staining for RV-specific CD8+ T cells. RV-responsive cells are ...
Tetramer staining for RV-specific CD8+ T cells. RV-responsive cells are mainly in α4β7hi population of orally but not subcutaneously immunized mice. Wt mice (C57BL/6) were immunized twice at a 15-day interval either subcutaneously or orally with RV as described. Thirty days following the last immunization, the splenocytes from immune mice were stained with anti-CD8 CyChrome; anti-CD19, anti-CD13, and anti-CD4 FITC; anti-α4β7 PE; and class I tetramer APC. Small lymphocytes were negatively gated on FITC-stained cells and positively gated on anti-CD8 CyChrome–stained cells. The gated cells were analyzed for α4β7 PE expression and tetramer-APC binding. Splenocytes from nonimmunized mice were stained simultaneously and were used as negative control. As negative control we also used APC-conjugated class I tetramer specific for irrelevant Ag. The gates for α4β7-negative cells and α4β7-expressing cells were set using splenocytes from β7–/– mice. The data represent one out of three experiments performed with similar results. Three mice per group were used in each experiment.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts